A Novel Ferroptosis-Related Pathway for Regulating Immune Checkpoints in Clear Cell Renal Cell Carcinoma

Su Gao1,2, Hailong Ruan3, Jingchong Liu3

  • 1Department of Geriatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Frontiers in Oncology
|August 9, 2021
PubMed

Insights

Ferroptosis, a cell death form, impacts clear cell renal cell carcinoma (ccRCC). Researchers identified a ferroptosis gene signature (FeSig) for diagnosis and prognosis, revealing a link to tumor immunity and the TAZ/WNT10B pathway for potential ccRCC immunotherapy.

Area of Science:

  • Oncology
  • Cell Biology
  • Immunology

Background:

  • Ferroptosis is a distinct form of programmed cell death implicated in various diseases, particularly cancers.
  • While ferroptosis is linked to clear cell renal cell carcinoma (ccRCC) progression, its precise molecular underpinnings remain largely unknown.
  • Understanding ferroptosis's role in ccRCC is crucial for developing novel therapeutic strategies.

Purpose of the Study:

  • To identify a ferroptosis-related gene signature for diagnosing and predicting outcomes in ccRCC.
  • To investigate the association between ferroptosis and tumor immunity in ccRCC.
  • To elucidate the molecular mechanisms, including potential regulatory pathways, underlying ferroptosis in ccRCC.

Main Methods:

  • Cox regression analysis was used to construct a four-gene signature (FeSig) based on ferroptosis-related genes.
  • Receiver Operating Characteristic (ROC) and survival analyses were performed to assess the diagnostic and prognostic capabilities of FeSig.
  • Weighted gene co-expression network analysis (WGCNA) was employed to identify potential regulatory mechanisms, followed by correlation and survival analyses.

Main Results:

  • The constructed four-gene signature (FeSig) demonstrated significant diagnostic and prognostic value in ccRCC.
  • Ferroptosis was found to be significantly associated with tumor immunity in the context of ccRCC.
  • The TAZ/WNT10B axis was identified as a key tumor immune-related regulatory pathway linked to ferroptosis in ccRCC.

Conclusions:

  • Ferroptosis plays a significant role in ccRCC and is closely correlated with the tumor immune microenvironment.
  • The TAZ/WNT10B signaling pathway emerges as a critical regulator in ferroptosis-associated immunity within ccRCC.
  • The TAZ/WNT10B axis presents a promising novel biomarker and therapeutic target for advancing immunotherapy in ccRCC.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
8.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.2K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.9K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.3K